{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:25:50Z","timestamp":1787185550805,"version":"build-2736575974"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K24173"],"award-info":[{"award-number":["23K24173"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K16480"],"award-info":[{"award-number":["22K16480"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K19348"],"award-info":[{"award-number":["24K19348"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"MEXT | Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJFR245P"],"award-info":[{"award-number":["JPMJFR245P"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP256f0137008"],"award-info":[{"award-number":["JP256f0137008"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02917-9","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:02:14Z","timestamp":1787184134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical-stage human anti-transferrin receptor antibodies suppress colorectal cancer metastasis"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7773-6841","authenticated-orcid":false,"given":"Mizuki","family":"Endo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3284-4796","authenticated-orcid":false,"given":"Takehiko","family":"Yokobori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilguun","family":"Erkhem-Ochir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Shirabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"2917_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","volume":"44","author":"AE Shin","year":"2023","unstructured":"Shin, A. E., Giancotti, F. G. & Rustgi, A. K. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharm. Sci. 44, 222\u2013236 (2023).","journal-title":"Trends Pharm. Sci."},{"key":"2917_CR2","doi-asserted-by":"crossref","unstructured":"Markopoulos, G. S. et al. Beyond iron: the roles of CD71 in the pathophysiology of cancer-a comprehensive review. J. Clin. Med. 14 (2025).","DOI":"10.3390\/jcm14238265"},{"key":"2917_CR3","doi-asserted-by":"publisher","first-page":"607692","DOI":"10.3389\/fimmu.2021.607692","volume":"12","author":"PV Candelaria","year":"2021","unstructured":"Candelaria, P. V., Leoh, L. S., Penichet, M. L. & Daniels-Wells, T. R. Antibodies targeting the transferrin receptor 1 (TfR1) as direct anticancer agents. Front Immunol. 12, 607692 (2021).","journal-title":"Front Immunol."},{"key":"2917_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/cpdd.1216","volume":"12","author":"Y Ogama","year":"2023","unstructured":"Ogama, Y. et al. Phase 1 clinical trial of PPMX-T003, a novel human monoclonal antibody specific for transferrin receptor 1, to evaluate its safety, pharmacokinetics, and pharmacodynamics. Clin. Pharm. Drug Dev. 12, 579\u2013587 (2023).","journal-title":"Clin. Pharm. Drug Dev."},{"key":"2917_CR5","doi-asserted-by":"publisher","first-page":"e098532","DOI":"10.1136\/bmjopen-2024-098532","volume":"15","author":"N Fukuhara","year":"2025","unstructured":"Fukuhara, N. et al. Protocol for a multicentre, open-label, dose-escalation phase I\/II study evaluating the tolerability, safety, efficacy and pharmacokinetics of repeated continuous intravenous PPMX-T003 in patients with aggressive natural killer cell leukaemia. BMJ Open 15, e098532 (2025).","journal-title":"BMJ Open"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02917-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02917-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02917-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:02:15Z","timestamp":1787184135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02917-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":5,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2917"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02917-9","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Mizuki Endo received PPMX-T003 from Perseus Proteomics Inc. Takehiko Yokobori received research funding from Perseus Proteomics Inc. Tadashi Matsuura received financial support from Perseus Proteomics Inc. None of the other authors declare any competing financial interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All animal experiments were approved by the Animal Care and Experimentation Committee of Gunma University (approval number: 23-069) and conducted in accordance with institutional guidelines. With respect to patient-derived xenograft (PDX) tumors. All patients provided written informed consent in accordance with institutional guidelines and the Declaration of Helsinki, and the study was approved by the Institutional Review Board for Clinical Research of Gunma University Hospital (approval no. HS2018-261).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"338"}}